cadila healthcare ltd.
Trade trend analysis
Mon
|
Year
Number of Transactions Quantity Weight
Number of Transactions Quantity Weight
The above chart presents the market trend analysis for cadila healthcare ltd. from 2025 to 2026. By examining various dimensions such as transaction quantity, transaction weight, average price, and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability. As of 2026, the company has completed 24 transactions, with a transaction quantity of 10209.12 and a transaction weight of 10209.12.
- Year Transactions Quantity Weight
- 2025 46 9071.77 8672.97
- 2026 24 10209.12 10209.12
Bill of lading data
< 1/15 >- Trade date 2026/07/27 B/L No. 92003000051592
- Suppliers cadila healthcare ltd. Buyers laboratorios la sante c.a.
- POLs —— PODs bogota
- Supply area India Purchas area Colombia
- Weight 366.2kg Amount 41165.45
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description DO 01263269 CODIGO OEA OE0355 DECLARACION 1 DE 2 FACTURA 2107424350 FECHA 24 06 2026 PEDIDO 4700063309 PRODUCTO Expand
- Trade date 2026/07/27 B/L No. 92003000046109
- Suppliers cadila healthcare ltd. Buyers laboratorios la sante c.a.
- POLs —— PODs bogota
- Supply area India Purchas area Colombia
- Weight 196kg Amount 41947.41
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description DO 01263249 CODIGO OEA OE0355PEDIDO 4700063410 DECLARACION 1 DE 2 FACTURA 2107424365 FECHA 28 06 2026 OC. 4700063 Expand
- Trade date 2026/07/27 B/L No. 92003000051618
- Suppliers cadila healthcare ltd. Buyers laboratorios la sante c.a.
- POLs —— PODs bogota
- Supply area India Purchas area Colombia
- Weight 521.71kg Amount 30539.84
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description DO 01263269 CODIGO OEA OE0355 DECLARACION 2 DE 2 FACTURA 2107424351 FECHA 24 06 2026 PEDIDO 4700063442 PRODUCTO Expand
- Trade date 2026/07/27 B/L No. 92003000046187
- Suppliers cadila healthcare ltd. Buyers laboratorios la sante c.a.
- POLs —— PODs bogota
- Supply area India Purchas area Colombia
- Weight 216.85kg Amount 47551.73
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description DO 01263249 CODIGO OEA OE0355PEDIDO 4700063410 DECLARACION 2 DE 2 FACTURA 2107424364 FECHA 28 06 2026 OC. 4700063 Expand
- Trade date 2026/07/14 B/L No. ——
- Suppliers cadila healthcare ltd. Buyers hemas pharmaceuticals pvt ltd.
- POLs —— PODs ——
- Supply area India Purchas area Sri Lanka
- Weight 4882.2kg Amount 37726.7
- Hs code 30049090 Product tags medicament,gel
- Product description MEDICAMENTS JONAC 30GM GEL M 014727 FR Expand
- Trade date 2026/07/14 B/L No. ——
- Suppliers cadila healthcare ltd. Buyers hemas pharmaceuticals pvt ltd.
- POLs —— PODs ——
- Supply area India Purchas area Sri Lanka
- Weight 292kg Amount 21286.8
- Hs code 30049090 Product tags medicament,alfa,mg ca
- Product description MEDICAMENTS ALFATAM 0 4MG CAPSULES M 015817 FR Expand
- Trade date 2026/07/14 B/L No. ——
- Suppliers cadila healthcare ltd. Buyers hemas pharmaceuticals pvt ltd.
- POLs —— PODs ——
- Supply area India Purchas area Sri Lanka
- Weight 225.5kg Amount 38839.2
- Hs code 30049090 Product tags medicament,abs,n 70
- Product description MEDICAMENTS ALDREN 70MG SERLIN 50MG TABS M 014566 FR M 014544 FR Expand
- Trade date 2026/06/01 B/L No. 92003008530316
- Suppliers cadila healthcare ltd. Buyers laboratorios la sante c.a.
- POLs —— PODs bogota
- Supply area India Purchas area Colombia
- Weight 443.5kg Amount 21889
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description X 30 TABLETAS C U) LOTE GB0102A MFG DATE 02 2026 EXP DATE 01 2028 SE TRATA DE 3634 UNIDADES (CAJAS X 30 TABLETAS C U) LOTE GB0101A MFG DATE 02 2026 EXP DATE 01 2028 SE TRATA DE 3668 UNIDADES (CAJAS X 30 TABLETAS C U) PARA UN TOTAL DE 11890 UNIDADES (CAJAS X 30 TABLETAS C U).MERCANCIA NUEVA IVA 0% DE ACUERDO AL ESTATUTO TRIBUTARIO ARTICULO 477 ANEXAMOS REGISTRO DE IMPORTACION NRO REG 50041678 20260302N CON FECHA DE APROBACION 2026 03 02 FECHA DE VIGENCIA 2026 09 02 VISTO BUENO INVIMA NRO VINVIMA 26 Expand
- Trade date 2026/06/01 B/L No. 92003008530323
- Suppliers cadila healthcare ltd. Buyers laboratorios la sante c.a.
- POLs —— PODs bogota
- Supply area India Purchas area Colombia
- Weight 203.99kg Amount 8203.5
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description CON DEMENCIA MODERADA A GRAVE DETIPO ALZHEIMER. TRATAMIENTO DE LOS DESIRDENES DE LA CONDUCTA EN NIÑOS ADOLESCENTES Y ADULTOS CON RETARDO MENTAL. COADYUVANTE A CORTO Y MEDIANO PLAZO EN EL MANEJO DE LA ENFERMEDAD DE AUTISMO. FORMA FARMACEUTICA TA TABLETA TIPO DE EMPAQUE 1R1014671008100 RISPERIDONA 2 0000 MG TABLETAS DE LIBERACION NO MODIFICADA ORAL (ZYRISP) TABLETA 1 0000U CAJA X 100 CAJA CON 10 BLISTER DE ALUMINIO PVC PVDC POR 10 TABLETAS C U CAJA CON Expand
- Trade date 2026/06/01 B/L No. 92003008530330
- Suppliers cadila healthcare ltd. Buyers laboratorios la sante c.a.
- POLs —— PODs bogota
- Supply area India Purchas area Colombia
- Weight 144.78kg Amount 44408.14
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description DE ORIGEN INDIA NO. DE EXPEDIENTE 20178284 REGISTRO SANITARIO INVIMA 2022M 0020710 VIGENCIA INDEFINIDA DE ACUERDO AL DECRETO 1474 DE 2023 ROL DEL IMPORTADOR IMPORTADOR TITULAR REGISTRO SANITARIO. LOTE GA1204A MFG DATE 11 2025 EXP DATE 10 2027 SE TRATA DE 4800 UNIDADES (CAJAS X 30 TABLETAS C U) LOTE GB0488A MFG DATE 04 2026 EXP DATE 03 2028 SE TRATA DE 4491 UNIDADES (CAJAS X 30 TABLETAS C U) PARA UN TOTAL DE 9291 Expand
- Trade date 2026/04/28 B/L No. 92003007541183
- Suppliers cadila healthcare ltd. Buyers laboratorios la sante c.a.
- POLs —— PODs bogota
- Supply area India Purchas area Colombia
- Weight 191.53kg Amount 40568.6
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description DO:01261804, CODIGO OEA OE0355PEDIDO 4700063132, DECLARACION 1 DE 1, // FACTURA:2107424143, FECHA:14-04-2026 PRODUCTO: M Expand
- Trade date 2026/03/10 B/L No. 92003006158114
- Suppliers cadila healthcare ltd. Buyers laboratorios la sante c.a.
- POLs —— PODs bogota
- Supply area India Purchas area Colombia
- Weight 222.16kg Amount 24519.55
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description DO:01260989, CODIGO OEA OE0355, DECLARACION 1 DE 2, // FACTURA:2107424008, FECHA:25-02-2026 PEDIDO: 4700062981 PRODUCTO: MEDICAMENTO DE USO HUMANO, LENIZAD¿ 50, NOMBRE COMERCIAL: LENIZAD¿ 50, PRINCIPIO ACTIVO: LACOSAMIDA, CONCENTRACION: 50 MG, INDICACIONES TERAPEUTICAS: LACOSAMIDA SE UTILIZA EN EL TRATAMIENTO DE LAS CRISIS DE INICIO PARCIAL EN PACIENTES CON O SIN GENERALIZACION SECUNDARIA CON EPILEPSIA. LACOSAMIDA ESTA INDICADO COMO MONOTERAPIA EN PACIENTES MAYORES DE 16 AÑOS O EN TERAPIA DE ADICION EN PACIENTES A PARTIR DE 4 AÑOS., FORMA FARMACEUTICA: TB - TABLETA RECUBIERTA, TIPO DE EMPAQUE: 1L1012291011100 - CAJA POR 3 BLISTERS DE PVC/PVDC - ALUMINIO POR 10 TABLETAS 50 MG DE LACOSAMIDA C/U, USO: MEDICAMENTO DE USO HUMANO, MARCA: LENIZAD¿ , CODIGO IUM NO: 1L1012291011100. LABORATORIO FABRICANTE: ZYDUS LIFESCIENCES LIMITED, DIRECCION FABRICANTE: KUNDAIM INDUSTRIAL ESTATE, PLOT N. 203 TO 213, KUNDAIM VILLAGE, GOA, 403 115 (SUCURSAL), PAIS DE ORIGEN: INDIA, NO. DE EXPEDIENTE: 20166087, REGISTRO SANITARIO:INVI Expand
- Trade date 2026/03/10 B/L No. 92003006158121
- Suppliers cadila healthcare ltd. Buyers laboratorios la sante c.a.
- POLs —— PODs bogota
- Supply area India Purchas area Colombia
- Weight 82.56kg Amount 12863.5
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description DO:01260989, CODIGO OEA OE0355, DECLARACION 2 DE 2, // FACTURA:2107424007, FECHA:25-02-2026 PEDIDO 4700063133 PRODUCTO: MEDICAMENTO DE USO HUMANO, LENIZAD¿ 150, NOMBRE COMERCIAL: LENIZAD¿ 150, PRINCIPIO ACTIVO: LACOSAMIDA, CONCENTRACION: 150 MG, INDICACIONES TERAPEUTICAS: LACOSAMIDA SE UTILIZA EN EL TRATAMIENTO DE LAS CRISIS DE INICIO PARCIAL EN PACIENTES CON O SIN GENERALIZACION SECUNDARIA CON EPILEPSIA. LACOSAMIDA ESTA INDICADO COMO MONOTERAPIA EN PACIENTES MAYORES DE 16 AÑOS O EN TERAPIA DE ADICION ENPACIENTES A PARTIR DE 4 AÑOS., FORMA FARMACEUTICA: TB - TABLETA RECUBIERTA, TIPO DE EMPAQUE: 1L1012311007100- CAJA POR 3 BLISTERS DE PVC/PVDC - ALUMINIO POR 10 TABLETAS 150 MG DE LACOSAMIDA C/U MUESTRA MEDICA CAJA POR 3 BLISTER DE PVC / PVDC ALUMINIO POR10 TABLETAS CADA UNA, USO: MEDICAMENTO DE USO HUMANO, MARCA: LENIZAD¿ , CODIGO IUM NO: 1L1012311007100. LABORATORIO FABRICANTE: ZYDUS LIFESCIENCES LIMITED, DIRECCION FABRICANTE: KUNDAIM INDUSTRIAL ESTATE, PLOT N. 203 TO 213, KUNDAIM VILLAGE, GOA, 403 115(SUCUR Expand
- Trade date 2026/03/06 B/L No. 92003006063344
- Suppliers cadila healthcare ltd. Buyers laboratorios la sante c.a.
- POLs —— PODs bogota
- Supply area India Purchas area Colombia
- Weight 353kg Amount 62498.5
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description DO:01261000, CODIGO OEA OE0355PEDIDO 4700062978, DECLARACION 1 DE 1, // FACTURA:2107424010, FECHA:25-02-2026 PRODUCTO: MEDICAMENTO DE USO HUMANO, LENIZAD¿ 200, NOMBRE COMERCIAL: LENIZAD¿ 200, PRINCIPIO ACTIVO: LACOSAMIDA, CONCENTRACION: 200 MG, INDICACIONES TERAPEUTICAS: LACOSAMIDA SE UTILIZA EN EL TRATAMIENTO DE LAS CRISIS DE INICIO PARCIAL EN PACIENTES CON O SIN GENERALIZACION SECUNDARIA CON EPILEPSIA. LACOSAMIDA ESTA INDICADO COMO MONOTERAPIA EN PACIENTES MAYORES DE 16 AÑOS O EN TERAPIA DE ADICION EN PACIENTES A PARTIR DE 4 AÑOS., FORMA FARMACEUTICA: TB - TABLETA RECUBIERTA, TIPO DE EMPAQUE: 1L1012321011100 - CAJA POR 3 BLISTERS DE PVC/PVDC - ALUMINIO POR 10 TABLETAS 200 MG DE LACOSAMIDA C/U, MUESTRA MEDICA: CAJA X 3 BLISTER DE PVC/PVDC ALUMINIO X 10 TABLETAS C/U., USO: MEDICAMENTO DE USO HUMANO, MARCA: LENIZAD¿ , CODIGO IUM NO: 1L1012321011100 . LABORATORIO FABRICANTE: ZYDUS LIFESCIENCES LIMITED, DIRECCION FABRICANTE: KUNDAIM INDUSTRIAL ESTATE, PLOT N. 203 TO 213, KUNDAIM VILLAGE, GOA, 403 115 (SUCURSAL) Expand
- Trade date 2026/03/05 B/L No. 92003005997471
- Suppliers cadila healthcare ltd. Buyers laboratorios la sante c.a.
- POLs —— PODs bogota
- Supply area India Purchas area Colombia
- Weight 257.97kg Amount 6230.26
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description DO:01260892, CODIGO OEA OE0355, DECLARACION 5 DE 5, // FACTURA:2107423971, FECHA:14-02-2026 PEDIDO: 4700063065; PRODUCTO: MEDICAMENTO DE USO HUMANO, ZYRISP ¿ 1 TABLETAS RECUBIERTAS, NOMBRE COMERCIAL: ZYRISP ¿ 1 TABLETAS RECUBIERTAS, PRINCIPIO ACTIVO: RISPERIDONA, CONCENTRACION: 1 MG, INDICACIONES TERAPEUTICAS: ALTERNATIVA EN LOS TRATAMIENTOS DE ESQUIZOFRENIA AGUDA Y CRONICA. MONOTERAPIA EN DESORDEN BIPOLAR. TRATAMIENTO DE AGITACION, AGRESION O SINTOMAS SIC¿TICOS EN PACIENTES CON DEMENCIA MODERADA A GRAVEDE TIPO ALZHEIMER. TRATAMIENTO DE LOS DESIRDENES DE LA CONDUCTA EN NIÑOS, ADOLESCENTES Y ADULTOS CON RETARDO MENTAL. COADYUVANTE A CORTO Y MEDIANO PLAZO EN EL MANEJO DE LA ENFERMEDAD DE AUTISMO., FORMA FARMACEUTICA: TA - TABLETA, TIPO DE EMPAQUE: 1R1027411007100 - RISPERIDONA 1,0000 MG TABLETAS DE LIBERACION NO MODIFICADA ORAL (ZYRISP) TABLETA 1,0000U / CAJA X 100 - CAJA CON 10 BLISTER DE ALUMINIO- PVC/PVDC POR 10 TABLETAS C/U, CAJA CON 3 BLISTER DE ALUMINIO- PVC/PVDC POR 10 TABLETAS C/U, MUESTRA MEDICA-CAJA Expand
Partners
Total 1356- Rank Company Transactions Per Detail
- 1 eversana life science services llc united statesbuyer,they trade on 2023-01-26 22938 12.66% >
- 2 dohmen life sciences services llc united statesbuyer,they trade on 2019-08-19 19275 10.64% >
- 3 sunshine heathcare lanka ltd. sri lankabuyer,they trade on 2023-12-18 8730 4.82% >
- 4 centre specialities pharmaceutiques francebuyer,they trade on 2022-05-31 4451 2.46% >
- 5 zydus nikkho farmaceutical ltda. brazilbuyer,they trade on 2025-06-01 4311 2.38% > +View All
Products
Total 164- Products Transactions Per Detail
-
tablet
58 19.59% > -
equipped with fixed dose drug
31 10.47% > -
heterocyclic compound
26 8.78% > -
pharm
26 8.78% > -
ah
20 6.76% >
+View All
Hscode rank
Total 772- HSCode Name Transactions Per Detail
- HS 30049090 95 32.09% >
- HS 3004902900 30 10.14% >
- HS 30049099 25 8.45% >
- HS 29339900 19 6.42% >
- HS 29339949900 9 3.04% > +View All
Port statistics
Total 88- Port Name Transactions Per Detail
- mundra 26405 14.57% >
- sahar air cargo acc inbom4 16395 9.05% >
- nhava sheva sea innsa1 9941 5.49% >
- delhi 6568 3.62% >
- thar dry port icd ahmedabad gujarat icd insau6 6324 3.49% > +View All
cadila healthcare ltd. is india Buyer&Supplier,
and primarily engages in the import and export business of products such as tablet，equipped with fixed dose drug，heterocyclic compound.
According to the 52wmb.com global trade database, as of 2026-07-27, the company has completed 181228 international trades,
The core products include HS30049090，HS3004902900，HS30049099 etc,
often transported via mundra，port sahar air cargo acc inbom4, port nhava sheva sea innsa1 etc,
and its main trading partners are eversana life science services llc，dohmen life sciences services llc，sunshine heathcare lanka ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on cadila healthcare ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.
Reference contact info
Email Hunting Tool